189 related articles for article (PubMed ID: 32470451)
1. Bcl2 inhibitor ABT737 reverses the Warburg effect via the Sirt3-HIF1α axis to promote oxidative stress-induced apoptosis in ovarian cancer cells.
Dong D; Dong Y; Fu J; Lu S; Yuan C; Xia M; Sun L
Life Sci; 2020 Aug; 255():117846. PubMed ID: 32470451
[TBL] [Abstract][Full Text] [Related]
2. ABT737 enhances ovarian cancer cells sensitivity to cisplatin through regulation of mitochondrial fission via Sirt3 activation.
Hou L; Wang R; Wei H; Li S; Liu L; Lu X; Yu H; Liu Z
Life Sci; 2019 Sep; 232():116561. PubMed ID: 31247208
[TBL] [Abstract][Full Text] [Related]
3. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L
Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875
[TBL] [Abstract][Full Text] [Related]
4. ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells.
Xie Q; Su J; Jiao B; Shen L; Ma L; Qu X; Yu C; Jiang X; Xu Y; Sun L
Int J Oncol; 2016 Dec; 49(6):2507-2519. PubMed ID: 27748803
[TBL] [Abstract][Full Text] [Related]
5. Nutrient Starvation Sensitizes Human Ovarian Cancer SKOV3 Cells to BH3 Mimetic via Modulation of Mitochondrial Dynamics.
Wang S; Mao Y; Xi S; Wang X; Sun L
Anat Rec (Hoboken); 2017 Feb; 300(2):326-339. PubMed ID: 27486855
[TBL] [Abstract][Full Text] [Related]
6. ABT737 induces mitochondrial pathway apoptosis and mitophagy by regulating DRP1-dependent mitochondrial fission in human ovarian cancer cells.
Yu Y; Xu L; Qi L; Wang C; Xu N; Liu S; Li S; Tian H; Liu W; Xu Y; Li Z
Biomed Pharmacother; 2017 Dec; 96():22-29. PubMed ID: 28963947
[TBL] [Abstract][Full Text] [Related]
7. ABT‑737, a Bcl‑2 family inhibitor, has a synergistic effect with apoptosis by inducing urothelial carcinoma cell necroptosis.
Cheng R; Liu X; Wang Z; Tang K
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33786632
[TBL] [Abstract][Full Text] [Related]
8. The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin.
Geserick P; Wang J; Feoktistova M; Leverkus M
Cell Death Dis; 2014 Sep; 5(9):e1412. PubMed ID: 25210795
[TBL] [Abstract][Full Text] [Related]
9. Lycium barbarum polysaccharides protect human trophoblast HTR8/SVneo cells from hydrogen peroxide‑induced oxidative stress and apoptosis.
Li J; Ding Z; Yang Y; Mao B; Wang Y; Xu X
Mol Med Rep; 2018 Sep; 18(3):2581-2588. PubMed ID: 30015960
[TBL] [Abstract][Full Text] [Related]
10. Euxanthone inhibits glycolysis and triggers mitochondria-mediated apoptosis by targeting hexokinase 2 in epithelial ovarian cancer.
Zou J; Wang Y; Liu M; Huang X; Zheng W; Gao Q; Wang H
Cell Biochem Funct; 2018 Aug; 36(6):303-311. PubMed ID: 29984416
[TBL] [Abstract][Full Text] [Related]
11. PEGylated anticancer-carbon nanotubes complex targeting mitochondria of lung cancer cells.
Kim SW; Kyung Lee Y; Yeon Lee J; Hee Hong J; Khang D
Nanotechnology; 2017 Nov; 28(46):465102. PubMed ID: 29053471
[TBL] [Abstract][Full Text] [Related]
12. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
[TBL] [Abstract][Full Text] [Related]
13. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
[TBL] [Abstract][Full Text] [Related]
15. SIRT3 participates in glucose metabolism interruption and apoptosis induced by BH3 mimetic S1 in ovarian cancer cells.
Xiang XY; Kang JS; Yang XC; Su J; Wu Y; Yan XY; Xue YN; Xu Y; Liu YH; Yu CY; Zhang ZC; Sun LK
Int J Oncol; 2016 Aug; 49(2):773-84. PubMed ID: 27277143
[TBL] [Abstract][Full Text] [Related]
16. BH3 mimetics activate multiple pro-autophagic pathways.
Malik SA; Orhon I; Morselli E; Criollo A; Shen S; Mariño G; BenYounes A; Bénit P; Rustin P; Maiuri MC; Kroemer G
Oncogene; 2011 Sep; 30(37):3918-29. PubMed ID: 21460857
[TBL] [Abstract][Full Text] [Related]
17. [Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells].
Chen ZJ; Zhang B; Pan SH; Zhao HM; Zhang Y; Feng WH; Li YY; Cao XC
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):891-5. PubMed ID: 22340096
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
[TBL] [Abstract][Full Text] [Related]
19. Glycolysis inhibition targets Mcl-1 to restore sensitivity of lymphoma cells to ABT-737-induced apoptosis.
Meynet O; Bénéteau M; Jacquin MA; Pradelli LA; Cornille A; Carles M; Ricci JE
Leukemia; 2012 May; 26(5):1145-7. PubMed ID: 22076465
[No Abstract] [Full Text] [Related]
20. Pro-survival responses to the dual inhibition of anti-apoptotic Bcl-2 family proteins and mTOR-mediated signaling in hypoxic colorectal carcinoma cells.
Risberg K; Redalen KR; Sønstevold L; Bjørnetrø T; Sølvernes J; Ree AH
BMC Cancer; 2016 Jul; 16():531. PubMed ID: 27461218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
